Clinical Trials in San Antonio

Showing 7201-7220 of 14,633 trials

Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

NCT03739593

This study will evaluate the safety, tolerability and efficacy of AR-1105 (dexamethasone implant) for the treatment of macular edema (ME) due to retinal vein occlusion (RVO). A more durable intravitreal implant containing a low dose of dexamethasone may result in less frequent retreatments, and potentially lower the incidence of steroid-related side effects without compromising efficacy.

Macular Edema

Aerie Pharmaceuticals49 participantsStarted Mar 2019

Phoenix, Arizona, United States • Beverly Hills, California, United States • Palo Alto, California, United States +8 more locations

COMPLETEDPhase 3< 1 mile

Mylan Insulin Aspart Study

NCT03760068

The aim of this phase III trial is to demonstrate the equivalence in the safety and efficacy profile between MYL-1601D and NovoLog® in patients with T1DM.

Diabetes Mellitus, Type 1

Mylan Inc.478 participantsStarted Nov 2018

Montgomery, Alabama, United States • Phoenix, Arizona, United States • Phoenix, Arizona, United States +155 more locations

Study Assessing AR-1105 in Subjects With Macular Edema Due to Retinal Vein Occlusion (RVO)

Mylan Insulin Aspart Study

Find Trials by Condition in San Antonio

A Comparison of Bimatoprost SR to Selective Laser Trabeculoplasty in Patients With Open-Angle Glaucoma or Ocular Hypertension

Herniorrhaphy Study for Opioid Elimination

TRanslesIonal Assessment of Gradients During Endovascular Therapy

Expanded Access Remdesivir (RDV; GS-5734™)

COVID-19 Positive Outpatient Thrombosis Prevention in Adults Aged 40-80

Study to Evaluate Safety and Efficacy of Dapagliflozin in Patients With Type 2 Diabetes Mellitus Aged 10-24 Years

Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer

Neoadjuvant Durvalumab Alone or in Combination With Novel Agents in Resectable Non-Small Cell Lung Cancer

PF-06651600 for the Treatment of Alopecia Areata

A Study Evaluating the Safety and Pharmacokinetics of Atezolizumab Administered in Combination With Hu5F9-G4 to Patients With Relapsed and/or Refractory Acute Myeloid Leukemia

Study to Evaluate Tezepelumab on Airway Inflammation in Adults With Uncontrolled Asthma (CASCADE)

A Study to Evaluate the Efficacy and Safety of Vedolizumab in the Treatment of Chronic Pouchitis

Extension Study Evaluating the Safety and Efficacy of Subcutaneous Tocilizumab (RoActemra/Actemra) Administration in Systemic and Polyarticular-Course Juvenile Idiopathic Arthritis

PEN-866 in Patients With Advanced Solid Malignancies

Safety and Efficacy of AMG 827 in Subjects With RA

A 42-day Parallel Group Safety Study of Revefenacin and Formoterol, Administered in Sequence and as a Combination, in Participants With COPD

RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma

Study to Evaluate a Single Dose of STI-2020 (COVI-AMG™) in Adults With Mild COVID-19 Symptoms